Jonathan Allan
GENERAL COUNSEL & CORP SEC
GENERAL COUNSEL & CORP SEC at Stoke Therapeutics, Inc., filing insider transactions between 2026-03-17 and 2026-03-20.
Total Purchases
—
0 transactions
Total Sales
$599K
7 transactions
Companies Traded
1
7 total filings
Active Since
2026-03-17
Last: 2026-03-20
Other Reporting Insiders at Stoke Therapeutics, Inc.
Transaction History
| Date | Ticker | Type | Shares | Price | Value | Owned After | |
|---|
| 2026-03-20 | STOK | Sale | 601 | $34.41 | $21K | 19.5K | SEC ↗ |
| 2026-03-20 | STOK | Sale | 8,692 | $33.64 | $292K | 20.1K | SEC ↗ |
| 2026-03-18 | STOK | Sale | 72 | $32.85 | $2K | 28.8K |
Director & Interim Executive Chair